Patents by Inventor Robert E. Newman

Robert E. Newman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND SYSTEMS FOR DEVELOPING MEDIA FOR EXTRACELLULAR VESICLE PRODUCTION
    Publication number: 20260022342
    Abstract: The present disclosure relates generally to methods and systems for the analysis, development, testing, and/or optimization, of culture media and/or culture conditions for extracellular vesicle production; culture media analyzed, developed, tested, and/or optimized via such assays; and to extracellular vesicles and compositions comprising extracellular vesicles generated using such culture media.
    Type: Application
    Filed: May 24, 2023
    Publication date: January 22, 2026
    Applicants: FUJIFILM Holdings America Corporation, FUJIFILM Irvine Scientific, Inc.
    Inventors: Ken NARUSE, Cassandra WRIGHT BELLVER, Alison FUJII, Aaron FULTON, Richard A. FESTA, Matthew TENORIO, David T. HO, Nisa RENAULT, Michele HAMRICK, Jacquelyn WONG, Robert E. NEWMAN, Maria Katerina R. VILLAFUERTE
  • PURIFIED MESENCHYMAL STEM CELL COMPOSITIONS AND METHODS OF PURIFYING MESENCHYMAL STEM CELL COMPOSITIONS
    Publication number: 20250312379
    Abstract: One or more purified mesenchymal stem cell pharmaceutical compositions and methods of manufacture utilizing centrifugal filtration are disclosed. Threshold limits for intravenous administration of mesenchymal stem cell pharmaceutical compositions comprising residual animal products are also disclosed.
    Type: Application
    Filed: March 20, 2025
    Publication date: October 9, 2025
    Inventors: Alla DANILKOVICH, Robert E. NEWMAN, Samson TOM, Christopher TON, Zhanling WANG, Randell G. YOUNG
  • PURIFIED MESENCHYMAL STEM CELL COMPOSITIONS AND METHODS OF PURIFYING MESENCHYMAL STEM CELL COMPOSITIONS
    Publication number: 20230089901
    Abstract: One or more purified mesenchymal stem cell pharmaceutical compositions and methods of manufacture utilizing centrifugal filtration are disclosed. Threshold limits for intravenous administration of mesenchymal stem cell pharmaceutical compositions comprising residual animal products are also disclosed.
    Type: Application
    Filed: September 23, 2022
    Publication date: March 23, 2023
    Inventors: Alla DANILKOVICH, Robert E. NEWMAN, Samson TOM, Christopher TON, Zhanling WANG, Randell G. YOUNG
  • PURIFIED MESENCHYMAL STEM CELL COMPOSITIONS AND METHODS OF PURIFYING MESENCHYMAL STEM CELL COMPOSITIONS
    Publication number: 20200197444
    Abstract: One or more purified mesenchymal stem cell pharmaceutical compositions and methods of manufacture utilizing centrifugal filtration are disclosed. Threshold limits for intravenous administration of mesenchymal stem cell pharmaceutical compositions comprising residual animal products are also disclosed.
    Type: Application
    Filed: November 25, 2019
    Publication date: June 25, 2020
    Inventors: Alla Danilkovich, Robert E. Newman, Samson Tom, Christopher Ton, Zhanling Wang, Randell Young
  • Methods, Systems, and Apparati for Cellular Therapeutic Agent Preparation and Delivery
    Publication number: 20110086010
    Abstract: Methods and devices for the preparation of a biological pharmaceutical composition outside of a classified environment, such as Biological Safety Cabinet type environment, are described. In one aspect of the present technology, a method is provided to prepare a biological pharmaceutical composition preferably in an area next to a patient's bedside or at a facility's pharmacy. The method comprises transferring an appropriate amount of a diluent from a diluent component (645) into a mixing receptacle (605) using a transfer device (620), connecting a pooling (630) harness between a biological pharmaceutical component (640) and the mixing receptacle, transferring a biological pharmaceutical composition through the pooling harness to the mixing receptacle, mixing the diluent and the biological pharmaceutical composition to form a biological pharmaceutical composition mixture and administering the biological pharmaceutical composition mixture to a patient for either flat based or weight based dosing needs.
    Type: Application
    Filed: April 23, 2008
    Publication date: April 14, 2011
    Inventors: Robert E. Newman, Roman M. Salasznyk